Literature DB >> 7889296

Characterization of the adenosine receptors mediating hypothermia in the conscious mouse.

R Anderson1, M J Sheehan, P Strong.   

Abstract

1. The effects of a range of adenosine receptor-selective ligands on body temperature were investigated following intracerebroventricular (i.c.v.) and intraperitoneal (i.p.) injection in conscious mice. The compounds tested were the non-selective adenosine receptor agonist 5'-N-ethyl-carboxamidoadenosine (NECA), the adenosine A1 receptor-selective agonists cyclopentyl-adenosine (CPA), N6-(9R-phenyl-isopropyl)-adenosine (R-PIA) and N-(1S,trans)-[2-hydroxyclopentyl]-adenosine (GR79236), the A2a receptor selective agonist 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxyamidoaden osine (CGS-21680), the A2b receptor agonist N-[(2-methylphenyl)methyl[adenosine (metrifudil) and the A3 receptor agonist N6-(4-aminophenylethyl)adenosine (APNEA). 2. NECA (0.01-1 microgram, i.c.v.), all of the A1-selective agonists (0.01-1 microgram, i.c.v.) and APNEA (0.1-3 micrograms i.c.v.) produced profound and dose-related hypothermia and sedation. However, CGS-21680 (0.1-10 micrograms i.c.v.) and metrifudil (0.01-1 microgram i.c.v.), produced only mild hypothermia at the highest doses tested. 3. The hypothermic response to the A1 receptor-selective agonists, GR79236 and R-PIA was dose-dependently antagonized by peripheral administration of either the non-selective adenosine receptor antagonist, 8-phenyltheophylline (8-PT, approximately 40 and 30 fold rightward shifts of the dose-response curves respectively at 10 mg kg-1, i.p.), or the adenosine A1 receptor-selective antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, approximately 20 fold shift of the GR79236 dose-response curve at 1 mg kg-1, i.p.). The hypothermic response to APNEA was similarly dose-dependently antagonized by the A1 receptor-selective antagonist, DPCPX (5 fold shift at 0.1 mg kg-1, i.p.). 4.8(p-Sulphophenyl)theophylline (8-SPT, 10 and 30 mg kg-1, i.p.), a non-selective adenosine receptorantagonist that penetrates the blood brain barrier poorly, produced only modest antagonism (approximately 2 fold shift at 30 mg kg-1, i.p.) of the hypothermic response to GR79236.5. These data suggest that hypothermia induced by adenosine analogues in the conscious mouse is mediated via adenosine A1 receptors, which are probably located in the CNS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889296      PMCID: PMC1510495          DOI: 10.1111/j.1476-5381.1994.tb17151.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Evidence for involvement of A1 adenosine receptors in neurotensin-induced hypothermia.

Authors:  F B Jolicoeur; D Menard
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

2.  Stimulation of adenosine A2 receptors induces catalepsy.

Authors:  S Ferré; A Rubio; K Fuxe
Journal:  Neurosci Lett       Date:  1991-09-16       Impact factor: 3.046

3.  Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680.

Authors:  M F Jarvis; M Williams
Journal:  Eur J Pharmacol       Date:  1989-09-13       Impact factor: 4.432

Review 4.  How does adenosine inhibit transmitter release?

Authors:  B B Fredholm; T V Dunwiddie
Journal:  Trends Pharmacol Sci       Date:  1988-04       Impact factor: 14.819

5.  1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.

Authors:  J W Daly; W Padgett; M T Shamim; P Butts-Lamb; J Waters
Journal:  J Med Chem       Date:  1985-04       Impact factor: 7.446

6.  Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression.

Authors:  R A Barraco; K A Martens; M Parizon; H J Normile
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

7.  2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands.

Authors:  A J Hutchison; M Williams; R de Jesus; R Yokoyama; H H Oei; G R Ghai; R L Webb; H C Zoganas; G A Stone; M F Jarvis
Journal:  J Med Chem       Date:  1990-07       Impact factor: 7.446

8.  Behavioral characteristics of centrally administered adenosine analogs.

Authors:  J W Phillis; R A Barraco; R E DeLong; D O Washington
Journal:  Pharmacol Biochem Behav       Date:  1986-02       Impact factor: 3.533

9.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.

Authors:  J Baumgold; O Nikodijevic; K A Jacobson
Journal:  Biochem Pharmacol       Date:  1992-02-18       Impact factor: 5.858

View more
  17 in total

1.  Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms.

Authors:  Jesse Lea Carlin; Shalini Jain; Elizabeth Gizewski; Tina C Wan; Dilip K Tosh; Cuiying Xiao; John A Auchampach; Kenneth A Jacobson; Oksana Gavrilova; Marc L Reitman
Journal:  Neuropharmacology       Date:  2016-11-30       Impact factor: 5.250

2.  Translating drug-induced hibernation to therapeutic hypothermia.

Authors:  Tulasi R Jinka; Velva M Combs; Kelly L Drew
Journal:  ACS Chem Neurosci       Date:  2015-04-08       Impact factor: 4.418

3.  Profound hypothermia after adenosine kinase inhibition in A1AR-deficient mice suggests a receptor-independent effect of intracellular adenosine.

Authors:  Christoph Eisner; SooMi Kim; Alexandra Grill; Yan Qin; Marion Hoerl; Josephine Briggs; Hayo Castrop; Manfred Thiel; Jurgen Schnermann
Journal:  Pflugers Arch       Date:  2016-12-14       Impact factor: 3.657

Review 4.  [Regulated hypothermia after cardiac arrest. A glimpse into the future].

Authors:  A Schneider; E Popp; B W Böttiger
Journal:  Anaesthesist       Date:  2006-12       Impact factor: 1.041

5.  Optimization of Thermolytic Response to A1 Adenosine Receptor Agonists in Rats.

Authors:  Isaac R Bailey; Bernard Laughlin; Lucille A Moore; Lori K Bogren; Zeinab Barati; Kelly L Drew
Journal:  J Pharmacol Exp Ther       Date:  2017-06-26       Impact factor: 4.030

6.  Central activation of the A1 adenosine receptor in fed mice recapitulates only some of the attributes of daily torpor.

Authors:  Maria A Vicent; Ethan D Borre; Steven J Swoap
Journal:  J Comp Physiol B       Date:  2017-04-04       Impact factor: 2.200

7.  G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responses.

Authors:  Alberto C S Costa; Melissa R Stasko; Markus Stoffel; Jonah J Scott-McKean
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

8.  Activation of adenosine A2A or A2B receptors causes hypothermia in mice.

Authors:  Jesse Lea Carlin; Shalini Jain; Romain Duroux; R Rama Suresh; Cuiying Xiao; John A Auchampach; Kenneth A Jacobson; Oksana Gavrilova; Marc L Reitman
Journal:  Neuropharmacology       Date:  2018-03-13       Impact factor: 5.250

9.  Circannual rhythm in body temperature, torpor, and sensitivity to A₁ adenosine receptor agonist in arctic ground squirrels.

Authors:  Jasmine M Olson; Tulasi R Jinka; Lindy K Larson; Jeffrey J Danielson; Jeanette T Moore; Joanna Carpluck; Kelly L Drew
Journal:  J Biol Rhythms       Date:  2013-06       Impact factor: 3.182

Review 10.  Is Adenosine Action Common Ground for NREM Sleep, Torpor, and Other Hypometabolic States?

Authors:  Alessandro Silvani; Matteo Cerri; Giovanna Zoccoli; Steven J Swoap
Journal:  Physiology (Bethesda)       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.